News for OXIS INTERNATIONAL INC (OXIS)

News for OXIS INTERNATIONAL INC
Date Headline
Jul 05, 2017 08:15 AM USPTO Approves and Issues Patent for Oxis-4235 to Treat Multiple Myeloma
Jun 26, 2017 08:00 AM Oxis Agrees to Acquire Georgetown Translational Pharmaceuticals, Appoints New Chief Executive Officer and Chief Medical Officer
Jun 13, 2017 08:30 AM Oxis Enters into a Co-Development Partnership Agreement with Altor Bioscience for Novel TriKE Therapeutic
May 03, 2017 08:15 AM Oxis International Expands Its State-Of-The-Art Trike Technology Portfolio
Apr 18, 2017 09:45 AM Oxis International Inc. Announces Treatment of First Patient in FDA Phase 2 Trial of Cancer Drug OXS-1550
Apr 04, 2017 08:30 AM Oxis International Inc. Announces Approval of FDA Phase 2 Trial with Its Bispecific Antibody OXS-1550
Mar 23, 2017 08:00 AM Oxis International Enters into a Sponsored Research Agreement with the University of Minnesota
Mar 21, 2017 08:00 AM OXIS Biotech Scientific Advisory Board Member to Address Cancer Immunotherapy Conference in China
Feb 21, 2017 08:15 AM Oxis Biotech Announces U.S. Patent and Trademark Office Notification of Patent Issuance for Oxis-4235 as Treatment for Multiple Myeloma
Jan 17, 2017 08:15 AM Oxis Biotech Announces Enrollment of 2 New Patients in FDA Clinical Trial of Promising Cancer Drug OXS-1550